Department of Endocrinology, Fuzhou General Hospital of Nanjing Military Command, No.156 Xi'er huan North Road, Fuzhou, Fujian, China.
J Endocrinol Invest. 2013 Jun;36(6):422-7. doi: 10.3275/8763. Epub 2012 Nov 27.
Oxidative stress appears to play a role in the pathogenesis of diabetes mellitus (DM), and disruption of the ubiquitin-proteasome system may underlie these pathological changes. We tested the effect of pioglitazone (PIO), an extract of Danshen dripping pill (DSP), and quercetin (QUE) on the pathogenesis of DM in a rat model.
Male Sprague Dawley rats were maintained in a normal control (NC) group or given a modified diet and streptozotocin (STZ) to induce DM. After STZ treatment, rats were given intragastric placebo, PIO, DSP, or QUE for 8 weeks. At the end of the treatment period, serum and urine chemistry, renal hypertrophy, renal histopathology, and renal expression of ubiquitin and nuclear factor (NF)-κB p65 were analyzed.
DM rats had altered body and kidney weight, altered serum and urine chemistry, increased accumulation of glomerular extracellular matrix (ECM), and increased renal expression of ubiquitin and NF-κB p65, indicating successful establishment of our DM model. Treatment with PIO, DSP, or QUE significantly ameliorated these pathological changes, although treated rats still had some symptoms of DM.
DM rats have increased expression of ubiquitin and NF-κB p65 in their renal tubules and glomeruli. PIO, DSP, and QUE ameliorated the pathological changes associated with DM and also reduced the renal expression of ubiquitin and NF-κB p65. These agents may provide protection from renal pathology associated with DM due to their anti-oxidant effects.
氧化应激似乎在糖尿病(DM)的发病机制中起作用,而泛素-蛋白酶体系统的破坏可能是这些病理变化的基础。我们测试了吡格列酮(PIO)、丹参滴丸(DSP)提取物和槲皮素(QUE)对 DM 大鼠模型发病机制的影响。
雄性 Sprague Dawley 大鼠维持在正常对照组(NC)或给予改良饮食和链脲佐菌素(STZ)诱导 DM。STZ 处理后,大鼠给予胃内安慰剂、PIO、DSP 或 QUE 治疗 8 周。治疗期末,分析血清和尿液化学、肾脏肥大、肾脏组织病理学以及肾脏中泛素和核因子(NF)-κB p65 的表达。
DM 大鼠的体重和肾脏重量发生改变,血清和尿液化学发生改变,肾小球细胞外基质(ECM)蓄积增加,肾脏中泛素和 NF-κB p65 的表达增加,表明成功建立了我们的 DM 模型。PIO、DSP 或 QUE 治疗可显著改善这些病理变化,尽管治疗大鼠仍有一些 DM 症状。
DM 大鼠的肾脏小管和肾小球中泛素和 NF-κB p65 的表达增加。PIO、DSP 和 QUE 改善了与 DM 相关的病理变化,同时减少了肾脏中泛素和 NF-κB p65 的表达。这些药物可能通过其抗氧化作用提供对与 DM 相关的肾脏病理的保护。